Coya Therapeutics Inc. (NASDAQ: COYA)
$5.4350
+0.1250 ( +2.35% ) 10.4K
Coya Therapeutics Inc is a clinical-stage biotechnology company focused on developing proprietary medicinal products to modulate the function of regulatory T cells. It is developing its multi-modality Treg therapies for neurodegenerative, autoimmune, and metabolic diseases.
Market Data
Open
$5.4350
Previous close
$5.3100
Volume
10.4K
Market cap
$90.64M
Day range
$5.3250 - $5.4800
52 week range
$4.7500 - $10.6899
SEC Filings
| Form Type | Description | Pages | Date |
|---|---|---|---|
| 4 | Insider transactions | 1 | Nov 14, 2024 |
| 4 | Insider transactions | 1 | Nov 13, 2024 |
| 4 | Insider transactions | 1 | Nov 12, 2024 |
| 4 | Insider transactions | 1 | Nov 12, 2024 |
| 10-q | Quarterly Reports | 56 | Nov 06, 2024 |
| 8-k | 8K-related | 12 | Nov 06, 2024 |
| 8-k | 8K-related | 13 | Nov 05, 2024 |
| 8-k | 8K-related | 15 | Oct 31, 2024 |
| 8-k | 8K-related | 31 | Oct 29, 2024 |
| 8-k | 8K-related | 15 | Oct 22, 2024 |